Impact of Pelvic Calcification Severity on Renal Transplant Outcomes: A Prospective Single-Center Study

Vascular calcifications (VC) are increasingly prevalent in patients with chronic kidney disease. This study aimed to assess the incidence of iliac artery calcifications in kidney transplant (KT) patients and explore the relationship between iliac VC burden measured by pelvic calcification score (PCS...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine Vol. 13; no. 20; p. 6171
Main Authors: Žuža, Iva, Dodig, Doris, Brumini, Ivan, Kutlić, Mate, Đurić, Robert, Katalinić, Nataša, Gršković, Antun, Jakšić, Ante, Mavrinac, Martina, Ćelić, Tanja, Rački, Sanjin, Orlić, Lidija, Nekić, Jasna, Markić, Dean
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 16-10-2024
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vascular calcifications (VC) are increasingly prevalent in patients with chronic kidney disease. This study aimed to assess the incidence of iliac artery calcifications in kidney transplant (KT) patients and explore the relationship between iliac VC burden measured by pelvic calcification score (PCS) and renal transplant outcomes. This prospective study involved 79 KT recipients. VC quantification, using a pre-transplant computed tomography (CT) scan, was performed by assessing calcifications in the common and external iliac arteries bilaterally, resulting in an overall PCS ranging from 0 (no calcifications) to 44 (extensive calcifications). Based on PCS values, patients were divided into three equal-sized groups: PCS Group 1 (PCS 0-4), PCS Group 2 (PCS 5-19), and PCS Group 3 (PCS > 19). Post-transplant outcomes tracked for at least 1 year were patient and graft survival, graft function (urea, creatinine, MAG-3 clearance), and incidence of MACE during the first post-transplant year. Calcifications were present in at least one arterial segment in 61 patients (77.2%). One-year patient survival was 95%, and one-year graft survival was 92.4%. Patients in PCS Group 3 had significantly lower one-year patient and graft survival compared to those in PCS Group 1 and 2 ( = 0.006 and = 0.008, respectively). MACE and renal function indicators 1-year post-transplant were similar across all PCS groups. Our study demonstrated that a significant majority of KT recipients exhibited iliac VC during pre-transplant CT assessments. Patients in PCS Group 3 exhibited significantly lower one-year patient and graft survival rates compared to those in PCS Groups 1 and 2, indicating that this subgroup may require more intensive post-transplant monitoring and management.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm13206171